DNLI

DENALI THERAPEUTICS INC

Healthcare | Mid Cap

-$0.72

EPS Forecast

$15.46

Revenue Forecast

Announcing earnings for the quarter ending 2025-06-30 soon
CRSPCrispr Therapeutics AgHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group IncNVAXNovavax IncTECHBio-techne CorpMRNAModerna IncNBIXNeurocrine Biosciences IncRGENRepligen Corp